OBJECTIVE: Women with ovarian carcinoma experience poor survival because symptoms are vague and diagnosis is unlikely at an early stage. The objective of this study was to identify a set of symptoms that might assist gynecologists and other clinicians in the diagnosis of localized ovarian carcinoma when treatment is most effective. METHODS: This population-based case-control study included 432 women, aged 19-88 years, with invasive ovarian carcinoma and 491 controls frequency-matched to cases on age, ethnicity, and interview time. Symptoms data were collected using interviewer-administered questionnaires. Odds ratios and 95% confidence intervals for the association of symptoms with ovarian carcinoma by stage and histology were estimated using unconditional multiple polytomous logistic regression models. The predictive ability of symptoms was evaluated by comparing the area under receiver operating curves (ROC). RESULTS: The following self-reported symptoms were significantly predictive of localized ovarian carcinoma irrespective of histological type: abdominal pain (ROC=0.81), distended and hard abdomen (ROC=0.83), vaginal bleeding not associated with periods (ROC=0.88), and a palpable abdominal mass (ROC=0.88). Urinary symptoms had low predictive ability, and bowel symptoms and fatigue/loss of appetite were predictive only at advanced stages. The best predictive ability was observed for a 4-symptom index that included abdominal pain, distended and hard abdomen, abdominal mass, and abnormal vaginal bleeding (ROC=0.90 sensitivity=74%; specificity=71%). CONCLUSION: Greater awareness of the symptoms potentially related to ovarian cancer might lead to earlier diagnosis and might improve survival.
OBJECTIVE:Women with ovarian carcinoma experience poor survival because symptoms are vague and diagnosis is unlikely at an early stage. The objective of this study was to identify a set of symptoms that might assist gynecologists and other clinicians in the diagnosis of localized ovarian carcinoma when treatment is most effective. METHODS: This population-based case-control study included 432 women, aged 19-88 years, with invasive ovarian carcinoma and 491 controls frequency-matched to cases on age, ethnicity, and interview time. Symptoms data were collected using interviewer-administered questionnaires. Odds ratios and 95% confidence intervals for the association of symptoms with ovarian carcinoma by stage and histology were estimated using unconditional multiple polytomous logistic regression models. The predictive ability of symptoms was evaluated by comparing the area under receiver operating curves (ROC). RESULTS: The following self-reported symptoms were significantly predictive of localized ovarian carcinoma irrespective of histological type: abdominal pain (ROC=0.81), distended and hard abdomen (ROC=0.83), vaginal bleeding not associated with periods (ROC=0.88), and a palpable abdominal mass (ROC=0.88). Urinary symptoms had low predictive ability, and bowel symptoms and fatigue/loss of appetite were predictive only at advanced stages. The best predictive ability was observed for a 4-symptom index that included abdominal pain, distended and hard abdomen, abdominal mass, and abnormal vaginal bleeding (ROC=0.90 sensitivity=74%; specificity=71%). CONCLUSION: Greater awareness of the symptoms potentially related to ovarian cancer might lead to earlier diagnosis and might improve survival.
Authors: Penelope M Webb; David M Purdie; Sonia Grover; Susan Jordan; Marie-Louise Dick; Adèle C Green Journal: Gynecol Oncol Date: 2004-01 Impact factor: 5.482
Authors: Galina Lurie; Lynne R Wilkens; Pamela J Thompson; Rayna K Matsuno; Michael E Carney; Marc T Goodman Journal: Gynecol Oncol Date: 2010-06-29 Impact factor: 5.482
Authors: Chioma O Erondu; Anthony J Alberg; Elisa V Bandera; Jill Barnholtz-Sloan; Melissa Bondy; Michele L Cote; Ellen Funkhouser; Edward Peters; Ann G Schwartz; Paul D Terry; Kristin Wallace; Lucy Akushevich; Frances Wang; Sydnee Crankshaw; Andrew Berchuck; Joellen M Schildkraut; Patricia G Moorman Journal: J Womens Health (Larchmt) Date: 2016-02-17 Impact factor: 2.681
Authors: James Dilley; Matthew Burnell; Aleksandra Gentry-Maharaj; Andy Ryan; Christina Neophytou; Sophia Apostolidou; Chloe Karpinskyj; Jatinderpal Kalsi; Tim Mould; Robert Woolas; Naveena Singh; Martin Widschwendter; Lesley Fallowfield; Stuart Campbell; Steven J Skates; Alistair McGuire; Mahesh Parmar; Ian Jacobs; Usha Menon Journal: Gynecol Oncol Date: 2020-06-17 Impact factor: 5.482
Authors: Garth Funston; Victoria Hardy; Gary Abel; Emma J Crosbie; Jon Emery; Willie Hamilton; Fiona M Walter Journal: Cancers (Basel) Date: 2020-12-08 Impact factor: 6.639
Authors: Sarah P Huepenbecker; Charlotte C Sun; Shuangshuang Fu; Hui Zhao; Kristin Primm; Sharon H Giordano; Larissa A Meyer Journal: Cancer Date: 2021-08-04 Impact factor: 6.860